跳到正文
EDQM 官方新闻与欧洲药典公告·AI 评分58

欧洲药典委员会批准设立3D打印药品工作组并征集专家

EPC approves creation of new working party on 3D-printed medicinal products

AI 导读

欧洲药典委员会在第185届会议批准设立3D打印药品工作组,为该技术在《欧洲药典》中的质量标准制定提供建议。工作组将评估药品3D打印技术对药典的相关性和潜在影响,确定需要新增或修订的药典文本,并向委员会提出后续工作建议,同时与其他药典专家组和特别工作组协调。EPC正征集在3D打印药品开发、生产、质量控制、审评或检查方面具备多年经验的专家加入该工作组。

正文 · 原文

EPC approves creation of new working party on 3D-printed medicinal products

EDQM Strasbourg, France 13/10/2026

Image 5: EPC approves creation of new working party on 3D-printed medicinal products

At its 185th Session in June 2026, the European Pharmacopoeia Commission (EPC) approved the creation of a new working party dedicated to exploring how best to provide quality standards for 3D-printed medicinal products in the European Pharmacopoeia (Ph. Eur.).

3D printing technologies are gaining momentum in the pharmaceutical sector, offering significant potential for the manufacture of personalised medicines and innovative dosage forms. The shift towards decentralised manufacturing is also expanding the role of 3D printing in pharmacies, particularly in the hospital setting. As these novel technologies continue to evolve, a clear need for appropriate quality standards to support their safe and effective implementation has emerged.

The newly created 3D-Printed Medicinal Products Working Party (3DP WP) will assess the relevance and potential impact of pharmaceutical 3D-printing technologies for the Ph. Eur. It will identify areas where new pharmacopoeial texts are needed or where existing texts should be revised, develop recommendations for future work and advise the EPC on appropriate strategies for addressing 3D printing within the Ph. Eur. The WP will work closely with other Ph. Eur. groups of experts and working parties to ensure a co-ordinated approach in this rapidly evolving field.

To support this work, the EPC invites expressions of interest from experts with several years of experience in pharmaceutical 3D printing, particularly in the development, manufacture, quality control, assessment or inspection of 3D-printed medicinal products. Additional expertise in pharmaceutical development, manufacturing or analytical procedures related to innovative technologies would be an asset.

If you have the knowledge and skills we are looking for and are willing to share them with us, this is a unique opportunity to help shape the future of Ph. Eur. standards for pharmaceutical 3D printing. Click on this link to find out how to join the new 3DP WP.

Find out more on the Terms of Reference and Profile for Members of Groups of Experts and Working Parties.

来源:EDQM 官方新闻与欧洲药典公告 · edqm.eu

所属事件

查看事件全部
欧洲药典委员会批准设立3D打印药品工作组